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Abstract Pointmutationsatm.8993T[Candm.8993T[G
of the mtDNA ATPase 6 gene cause the neurogenic weak-
ness, ataxia and retinitis pigmentosa (NARP) syndrome, a
mitochondrial disorder characterized by retinal, central and
peripheral neurodegeneration. We performed detailed neu-
rological, neuropsychological and ophthalmological phe-
notyping of a mother and four daughters with NARP
syndrome from the mtDNA m.8993T[C ATPase 6 muta-
tion, including 3-T brain MRI, spectral domain optical
coherence tomography (SD-OCT), adaptive optics scanning
laser ophthalmoscopy (AOSLO), electromyography and
nerve conduction studies (EMG-NCS) and formal neuro-
psychological testing. The degree of mutant heteroplasmy
for the m.8993T[C mutation was evaluated by real-time
allele refractory mutation system quantitative PCR of
mtDNA from hair bulbs (ectoderm) and blood leukocytes
(mesoderm). There were marked phenotypic differences
betweenfamilymembers,evenbetweenindividualswiththe
greatest degrees of ectodermal and mesodermal hetero-
plasmy. 3-T MRI revealed cerebellar atrophy and cystic and
cavitary T2 hyperintensities in the basal ganglia. SD-OCT
demonstrated similarly heterogeneous areas of neuronal
and axonal loss in inner and outer retinal layers. AOSLO
showed increased cone spacing due to photoreceptor loss.
EMG-NCS revealed varying degrees of length-dependent
sensorimotor axonal polyneuropathy. On formal neuropsy-
chological testing, there were varying deﬁcits in processing
speed, visual–spatial functioning and verbal ﬂuency and
high rates of severe depression. Many of these cognitive
deﬁcits likely localize to cerebellar and/or basal ganglia
dysfunction. High-resolution retinal and brain imaging in
NARPsyndromerevealedanalogouspatternsoftissueinjury
characterized by heterogeneous areas of neuronal loss.
Keywords Mitochondrial disorders  
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Introduction
All nucleated cells in the human body contain mitochon-
dria, the organelles responsible for intracellular energy
production [1]. Each mitochondrion carries multiple copies
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DOI 10.1007/s00415-010-5775-1of maternally inherited, circular, double-stranded mitochon-
drial DNA (mtDNA), which encodes for 2 rRNA, 22 tRNA,
and 13 protein subunits essential for oxidative phosphoryla-
tion. Autosomal genes encode for all other mitochondrial
proteins [1]. Mitochondrial DNA mutations are an important
cause of neurodegeneration [2–4], and autosomally encoded
mitochondrial proteins have also been implicated in a wide
range of neurodegenerative conditions [5].
Point mutations at position 8993 of the mtDNA ATPase
6 gene cause neurogenic weakness, ataxia and retinitis
pigmentosa (NARP) syndrome, a neurodegenerative dis-
order of the retina and central and peripheral nervous
systems. The syndrome is named for its clinical manifes-
tations: sensorimotor axonal polyneuropathy, ataxia, reti-
nitis pigmentosa (RP), sensorineural hearing loss, seizures
and cognitive impairment [6–10]. The same ATPase 6
point mutations that cause NARP syndrome also cause
maternally inherited Leigh syndrome (MILS), a subacute
necrotizing encephalomyelopathy that is a ﬁnal common
phenotype for a number of mutations associated with
impaired energy production [11]. Since many patients with
ATPase 6 mtDNA point mutations exhibit phenotypes that
overlap with NARP and MILS, these previously discrete
syndromes are probably best understood as part of a shared
phenotypic spectrum [9].
Phenotypic variability is a cardinal feature of NARP and
MILS [6, 9, 12, 13]. Mitochondrial genetic heteroplasmy,
the ratio of mutant to wild-type mtDNA, helps to explain
some of this variability, as greater degrees of mutant het-
eroplasmy tend to lead to more severe clinical deﬁcits [1,
3]. In NARP/MILS, the risk of developing severe func-
tional disability increases greatly past a threshold of
[60–70% mutant blood heteroplasmy for the m.8993T[G
ATPase 6 mutation and[80–90% blood heteroplasmy for
the m.8993T[C mutation [12, 14]. Environmental, auto-
somal and tissue-speciﬁc factors may also modulate dis-
ease expression [15, 16].
To better characterize the range of disease expression in
NARP syndrome from the m.8993T[C mutation, we per-
formed detailed phenotyping of retinal, central and
peripheral disease expression in ﬁve family members with
NARP syndrome from the m.8993T[C mutation.
Methods
Subjects
We evaluated a mother (M1) and four daughters (D1–D4)
with the m.8993T[C mtDNA ATPase 6 point mutation.
The family was of Spanish and Colombian descent. M1 had
one brother with coordination problems, four unaffected
siblings, and a maternal aunt who had lost all four children
in infancy from unknown causes. The father of D1–D4
suffered from bipolar disease.
All participants provided written informed consent. The
Institutional Review Boards of UCSF and UC Berkeley
approved the study protocol, and the study was performed
in accordance with the Declaration of Helsinki.
Neurological evaluation
A study neurologist (A.G.) performed a comprehensive
neurological examination of all ﬁve subjects. An electro-
physiologist (L.G.) performed electromyography and nerve
conduction studies (EMG-NCS) in three subjects.
Neuropsychological evaluations
All subjects underwent a brief interview regarding their
cognitive function and approximately 2 h of formal neu-
ropsychological testing using measures of global cognition,
intellectual ability, verbal memory, visual-constructional
skills and recall, working memory, processing speed,
executive function, verbal ﬂuency, language, reading,
depression and anxiety (Electronic supplementary mate-
rial). All results were converted to standard scores based on
age-appropriate normative data; education-corrected nor-
mative data were also utilized when available.
3-T MRI evaluation
Four subjects had a research-quality brain MRI scan (Tim
Trio 3-T MR scanner with a 12-channel head coil; Siemens
Medical, Germany) which included T1 MPRAGE, T2 TSE,
FLAIR, diffusion, ADC and proton-density sequences; the
ﬁfth subject (D3) had a clinical MRI scan at age 18 years,
which was also analyzed. A study neuroradiologist inter-
preted the images.
Ophthalmological evaluation
All subjects underwent a comprehensive ophthalmological
evaluation, including slit lamp and dilated fundus exami-
nation, best-corrected visual acuity using a standard eye
chart, visual ﬁeld testing, color vision testing, high-reso-
lution spectral domain optical coherence tomography (SD-
OCT, Spectralis
 HRA ? OCT system, Spectralis
 3.1
software; Heidelberg Engineering, Vista, CA) and full-ﬁeld
electroretinography (ERG), as reported previously [17].
Those with stable ﬁxation also underwent multifocal ERG
(mfERG, VERIS 5.1.10X; Electro-Diagnostic Imaging,
Redwood City, CA) using a Burian-Allen contact lens
electrode, following ISCEV standards as previously
described [17]. Three subjects underwent adaptive optics
scanning laser ophthalmoscopy (AOSLO) imaging with
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123cone spacing analysis using customized equipment and
software at the UC Berkeley School of Optometry [17–21].
Mitochondrial DNA point mutation analysis
Twenty different hair bulb samples (ectoderm) from three
different scalp locations were obtained from each subject,
and the DNA was extracted and ampliﬁed using PCR. Total
DNA from blood leukocytes was also extracted from
whole-blood samples (mesoderm) and ampliﬁed with PCR
using speciﬁc primer pairs. The presence of the hetero-
plasmic m.8993T[C mutation was detected by allele-spe-
ciﬁc oligonucleotide dot blot analyses followed by
quantiﬁcation of the degree of heteroplasmy using real-time
allele refractory mutation system (ARMS) quantitative PCR
[22, 23]. The primers used for real-time ARMS-qPCR were:
forward wild-type (ARMS T8993-1m) 50-TACTCATT
CAACCAATAGCCaT-30, mutant type (ARMST8993C-
1m )5 0-TACTCATTCAACCAATAGCCaC-30, and shared
reverse primer (mtR9046) 50-TTAGGTGCATGAGTAG
GTGGC-30. The analyses of the testing samples were
repeated four times using the pooled DNA samples and
quality control samples with known heteroplasmy content.
The reaction was run in duplicate for each analysis. The
intrarun and interrun differences were less than 20 and 30%,
respectively. The ﬁnal heteroplasmy rate was calculated by
averaging the values obtained in duplicate runs [17].
Results
Table 1 summarizes the range of neurological, neuropsy-
chological and ophthalmological disease expression in this
family with NARP syndrome.
Genotype–phenotype correlation
The four family members with mutant heteroplasmy
greater than 78% in the blood and 87% in the hair bulbs
suffered from sensorimotor axonal polyneuropathy and
RP, and the three daughters with the greatest degree of
mutant heteroplasmy ([78% in the blood and 99% in the
hair bulbs) also had ataxia and cerebellar degeneration.
Heteroplasmy rates were greater in pooled hair bulb
s a m p l e st h a ni nb l o o d .T h e r ew a s marked variability in the
types of tissues affected within individuals. For example,
one daughter with 99.9% hair bulb and 78% leukocyte
heteroplasmy (D1) suffered from moderate ataxia and
severe RP, while her sister with 99% hair bulb and 95%
leukocyte heteroplasmy (D3) had severe ataxia but only
moderate RP.
The age at time of ﬁrst symptom ranged from ataxia at
13 months in subject D3 to visual impairment at 10, 12 and
34 years in D4, D1 and M1, respectively, which also cor-
related inversely with heteroplasmy.
Peripheral neurodegeneration
Four of the ﬁve subjects (all except D2) had evidence of
peripheral neuropathy on clinical examination, most com-
monly characterized by large-ﬁber sensory deﬁcits and
absent S1 deep-tendon reﬂexes. Three subjects underwent
EMG-NCS, which revealed decreased or absent sural
sensory nerve action potential amplitudes, and long-dura-
tion, high-amplitude motor unit action potentials and
reduced recruitment in the abductor hallucis longus. These
ﬁndings are consistent with a length-dependent sensori-
motor axonal polyneuropathy.
Cerebellar degeneration
The three subjects (D1, D3 and D4) with the greatest
degrees of blood and hair bulb heteroplasmy suffered from
ataxia, with varying combinations of dysmetria, dysdiad-
ochokinesia, tremor, dysarthria, imbalance, saccadic over-
shoot, end-gaze jerk nystagmus, and impaired tandem gait.
Truncal stability was preserved in all subjects. While all
patients experienced chronic, progressive worsening of
cerebellar symptoms over time, two of the three subjects
(D3 and D4) also experienced additional, punctuated epi-
sodes of profound worsening of ataxia, which were asso-
ciated temporally with adolescence, oral contraceptive pills
and pregnancy.
3-T MRI: cerebellar and basal ganglia abnormalities
MRI of the brain was abnormal in all ﬁve family members,
but the severest abnormalities occurred in those with the
greatest degrees of mutant heteroplasmy (Table 1; Fig. 1a).
The lesions involved the bilateral putamen in all subjects
and the anterior commissure, frontal gyrus recti and cau-
date heads in the most affected subjects. All three daugh-
ters with ataxia (D1, D3 and D4) showed cerebellar atrophy
on MRI scans (Fig. 1b), and the degree of atrophy corre-
lated with the severity of the clinical deﬁcit. D3 had diffuse
cortical, corpus callosal, pontine and cervical cord atrophy,
and M1, the oldest subject, also had mild global brain
atrophy.
Neuropsychological proﬁles
The most consistent cognitive deﬁcits in this family were
impairments in processing speed, visual-spatial copy and
recall and verbal ﬂuency (see Table 1; Electronic Supple-
mentary Material). D1, who had severe visual deﬁcits from
RP, had mild verbal ﬂuency impairment. M1 and D4 had
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123Table 1 Phenotypic characterization of a family with NARP syndrome from the m.8993T[C ATPase 6 mutation
Mother (Ml) Daughter 1 (Dl) Daughter 2 (D2) Daughter 3 (D3) Daughter 4 (D4)
Age (years) 48 28 26 22 16
Hair-bulb
heteroplasmy (%)
87 99 54 99 99
Leukocyte
heteroplasmy (%)
78 78 42 95 92
Clinical symptoms RP, mild numbness,
weakness,
depression
Severe RP, moderate
ataxia, neuropathy,
weakness, depression
Remote history
of depression
with suicidal
ideation
Severe ataxia, moderate
RP, remote depression
Severe RP, episodic mild
ataxia, mild depression
Neurological
examination
Mild asymmetric
weakness, absent
triceps and S1
reﬂexes, decreased
pain and vibration
sense in the feet
Lingual dysarthria,
moderate proximal
weakness, mildly
decreased vibration
sense in the feet,
moderate dysmetria,
impaired tandem
(straight line) gait
Normal Nystagmus, saccadic
breakdown, dysarthria,
moderate weakness,
spasticity, absent S1
reﬂex, dysmetria,
tremor, impaired
tandem (straight line)
gait, decreased pain
and vibration sense in
the feet
Overshot saccades, mild
proximal weakness,
moderate dysmetria
and
dysdiadochokinesia,
decreased S1 reﬂexes,
decreased pain and
vibration sense in the
feet
EMG-NCS Sensorimotor axonal
polyneuropathy
Not done Not done Sensorimotor axonal
polyneuropathy
Sensorimotor axonal
polyneuropathy
MRI Cystic/cavitary T2
hyperintensities in
the bilateral
putamina and globus
pallidi, mild
cerebellar atrophy,
mild global volume
loss
Cystic/cavitary T2
hyperintensities in
bilateral putamina,
anterior commissure,
frontal gyrus recti,
cerebellar atrophy
Mild T2 cystic/
cavitary
changes in
basal ganglia
(Performed at age
18 years) Diffuse
atrophy of cortex,
cerebellum and
cervical cord, T2
cystic/cavitary basal
ganglia
hyperintensities
Cystic/cavitary T2
hyperintensities in the
anterior putamina and
caudate heads, mild
cerebellar atrophy
Neuropsychological
testing
MMSE 29/30;
selective
impairments in
information
processing speed,
set-shifting, and
visual-spatial skills
MMSE 27/27 (excluding
visual tasks); selective
mild deﬁcits in verbal
ﬂuency
MMSE 29/30;
grossly normal
with the
exception of
slightly
variable
information
processing
speed
MMSE 27/30; relative
sparing of verbal
abilities with
impairments in motor
speed, information
processing speed,
visual-spatial skills and
memory
MMSE 30/30; selective
impairments in motor
speed, information
processing speed,
verbal ﬂuency, and
visual recall (despite
adequate copy
performance)
Mood Moderate depression
with suicidal
ideation
Severe depression with
moderate anxiety,
despite antidepressant
therapy; remote history
of suicide attempt
Remote history
of depression
with suicidal
ideation
Remote history of
depression
Mild depression with
severe anxiety
Best-corrected
visual acuity
20/50 5/125 20/16 20/25 20/50
High-resolution
optical coherence
tomography
Moderate–severe
photoreceptor layer
thinning, with mild
involvement of
retinal nerve ﬁber
layer
Severe foveal thinning,
including
photoreceptor layer,
retinal pigment
epithelial layer and
retinal nerve ﬁber
layer/ganglion cell
layer
Not done Patchy ring of
photoreceptor/retinal
nerve ﬁber layer
thinning
Progressive thinning of
the temporal
photoreceptor/retinal
nerve ﬁber layer
RP retinitis pigmentosa, MMSE mini-mental state examination
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123signiﬁcant deﬁcits in information processing speed and
visual-spatial functioning (see Fig. 2). D3, who suffered
the severest cerebellar injury, had deﬁcits in processing
speed, motor speed, memory and visual-spatial function-
ing. D2, who was unaffected clinically, tested normally in
all cognitive domains. The mini-mental state examination
was an insensitive screen for cognitive deﬁcits in this
family, as it was near normal in all subjects (range 27/
30–30/30).
Affective symptoms were prominent in this family, with
all ﬁve family members having a signiﬁcant history of
depression, many with suicidal ideation. D3 subsequently
developed severe psychosis and depression requiring psy-
chiatric hospitalization.
Retinal neurodegeneration
Four of the ﬁve subjects demonstrated varying degrees of
RP. The best-corrected visual acuity (BCVA) ranged from
20/25 in mild RP (D3) to 5/125 in severe RP (D1). Retinal
vascular attenuation was present in all affected subjects,
while bone-spicule pigmentary changes and retinal pig-
ment epithelium atrophy were observed in those with
severe RP. Full-ﬁeld ERG demonstrated varying degrees of
decreased rod-mediated, cone-mediated and mixed rod-
and cone-mediated amplitudes, while multifocal ERG
revealed that the macular photoreceptors had the greatest
functional impairment, with relative sparing of more
peripheralphotoreceptors. SD-OCT (Figs. 1and3)revealed
macular thinning, especially of the photoreceptor (RPE)
layer,butalsothinningoftheretinalnerveﬁberandganglion
celllayersinproportion tothe severity ofRP. AOSLO in the
four subjects capable of stable ﬁxation revealed increased
cone spacing with variable degrees of patchy cone loss and
abnormally enlarged foveal cones (Fig. 3d). There was
normal cone spacing on AOSLO in subject D2, who had no
visual symptoms (Fig. 3e) [17].
Discussion
We describe the range of retinal, peripheral and central
nervous system disease expression in a single family with
NARP syndrome from the ATPase 6 m.8993T[C mtDNA
point mutation. Even amongst family members with the
greatest degrees of ectodermal and mesodermal hetero-
plasmy, there was great variability in tissue types affected
and severity of injury within those tissues.
All subjects in our series had greater degrees of hair-
bulb heteroplasmy than blood leukocyte heteroplasmy, but
the overall trends were similar. Family members with the
greatest degrees of hair-bulb and leukocyte heteroplasmy
suffered the severest neurological and ophthalmological
deﬁcits, but neither hair-bulb nor leukocyte heteroplasmy
Fig. 1 High-resolution retinal
and brain imaging in NARP
syndrome demonstrates
analogous patterns of tissue
injury. This 28-year-old woman
(D1) with NARP syndrome
from the mtDNA ATPase
6 m.8993T[C mutation with
78% blood leukocyte and 99%
hair-bulb heteroplasmy had
severe RP and moderate ataxia.
a, b 3-T MRI demonstrates
cystic and cavitary T2
hyperintensities in the bilateral
putamina (a), likely reﬂecting
neuronal necrosis, and also
moderate cerebellar atrophy
with T1 imaging (b). c High-
resolution OCT image of the
macula demonstrates severe
retinal thinning, primarily due
to degeneration of the
photoreceptor and the retinal
pigment epithelial cell layers,
but also associated thinning of
the ganglion cell (GCL) and
retinal nerve ﬁber layer (RNFL).
d Macular OCT image from an
age-similar normal female
shown for comparison
444 J Neurol (2011) 258:440–448
123uniformly predicted which tissues would be affected in a
given individual or the severity of deﬁcits within a given
tissue (Table 1).
There were analogous patterns of tissue injury on high-
resolution retinal and brain imaging characterized by het-
erogeneous, patchy areas of neuronal loss (Figs. 1c, d, and
3d, e). With 3-T MRI, we were able to appreciate that the
basal ganglia hyperintensities typical of NARP-MILS
spectrum disease [12, 13, 24] are not homogeneous, but
rather consist of multiple, small cystic and cavitary lesions.
These basal ganglia hyperintensities likely reﬂect discrete
foci of tissue loss from mitochondria-related energy failure
[13]. Since basal ganglia necrosis is also a deﬁning feature
of MILS, the prominence of this ﬁnding in our study
reinforces the concept that NARP and MILS reﬂect over-
lapping phenotypes of ATPase 6 dysfunction [3, 6, 9, 12,
13].
We observed similar patterns of heterogeneous, focal
and destructive injury to neuronal layers of the inner and
outer retina. On SD-OCT, the most prominent abnormality
was thinning of the photoreceptor (RPE) layer with scat-
tered areas of severe neuronal loss causing a disruption to
normal retinal architecture. There was also associated
thinning of the retinal nerve ﬁber and ganglion cell layers
in proportion to the degree of RPE injury. Since RNFL
thinning is common in other types of retinitis pigmentosa
[25] and the severest injury was to the outer retina, we
suspect that the primary retinal injury in NARP syndrome
is to energy-dependent photoreceptors followed by sec-
ondary transsynaptic degeneration of neighboring retinal
layers [26]. The abnormalities observed on SD-OCT and
AOSLO are also consistent with ﬁndings on retinal
pathology from a child who died from MILS from the
m.8993T[G mutation [27], and illustrate how high-reso-
lution retinal imaging can detect neurodegenerative injury
in a mitochondrial disorder.
Our study demonstrates that cognitive impairment in
NARP-MILS is characterized by selective dysfunction of
speciﬁc functional domains, especially in information pro-
cessing speed, visual-spatial copy and memory and verbal
ﬂuency. The visual-spatial deﬁcits were independent of the
degree of primary visual loss from RP (see Fig. 2). Visual-
spatial and executive function impairment are characteristic
of other mitochondrial cytopathies, such as chronic pro-
gressive external ophthalmoplegia and Kearns-Sayre syn-
drome, and the localization of these deﬁcits has been
attributed to the prefrontal, parietal and occipital cortex [28,
29]. However, cerebellar dysfunction also causes deﬁcits in
executive functioning, verbal ﬂuency, memory and visual-
spatial processing [30], and striatal networks also modulate
many cognitive processes, including language, and execu-
tive and visual-spatial functioning [31, 32]. Given the
extensive cerebellar and basal ganglia injury seen in NARP
syndrome with relative sparing of cortical structures, we
propose that some of the cognitive deﬁcits characteristic of
NARP-MILS spectrum disease may be due to cerebellar
and basal ganglia dysfunction. Our results also suggest that
the mini-mental state examination is not an adequate
screening test for cognitive dysfunction in NARP syn-
drome, and that clinicians should pursue more sensitive
evaluations focused on information processing speed, ver-
bal ﬂuency and visual-spatial function.
Two main factors argue against depression confounding
the neuropsychological testing results [33]. First, all sub-
jects showed similar patterns of deﬁcits, despite variability
in affective symptoms. Second, verbal and working mem-
ory tend to be impaired when depression causes cognitive
deﬁcits [34], but these domains were not signiﬁcantly
affected in this family, even in those subjects with the
severest depression. Depression has not traditionally been
recognized as part of the NARP-MILS phenotypic spec-
trum, but the prominence of affective symptoms in this
family raises the question as to whether mitochondrial
dysfunction may be involved in its pathogenesis [35].
Depression is common in mitochondrial cytopathies [36,
Fig. 2 Visual-spatial deﬁcits in NARP syndrome reﬂect impaired
cognitive functioning, not just poor vision. Subject D4, despite
moderate RP causing impaired vision, had normal visual-spatial
constructional skills using the Rey-Osterrieth complex ﬁgure, but
exhibited deﬁcits in visual-spatial recall. On the other hand, M1
a n dD 3 ,w h ob o t ha l s os u f f e r e df r o mm o d e r a t et os e v e r eR P ,h a d
difﬁculty with both visual copy and visual recall (D1 could not
perform either of the tasks due to severe visual loss). D2, who
was clinically unaffected, performed normally on both tasks
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12337], and is also prominent in other neurodegenerative
disorders that affect striatal networks, including Hunting-
ton’s and Parkinson’s diseases [38, 39]. In our analysis,
however, we were not able to account for other factors that
might have inﬂuenced depression risk in this family,
including the history of bipolar disease in the father of D1–
D4 or shared environmental exposures. More research is
needed to explore this possible association between
depression and mitochondrial disease further.
There are several limitations to this study. We character-
ized disease expression in a single family, which risks over-
emphasizing shared autosomal or environmental factors that
can inﬂuence mitochondrial disease expression or confound
phenotypes. It is also difﬁcult in this kind of analysis to
account for the effects of age on mitochondrial disease pro-
gression. We also did not measure heteroplasmy using the
urinary epithelium, which has been recently reported to pre-
dictneurologicalinvolvement inMELAS [40]. Nevertheless,
we believe that this study adds to our understanding of the
range of phenotypic expression seen in this prototypical
mitochondrial neurodegenerative disorder.
In summary, this study characterized patterns of disease
expression in NARP syndrome from the m.8993T[C
ATPase 6 mtDNA mutation and illustrated how neurode-
generation in the retina, brain and peripheral nervous sys-
tem can share common mechanisms.
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